GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scandinavian ChemoTech AB (OSTO:CMOTEC B) » Definitions » Equity-to-Asset

Scandinavian ChemoTech AB (OSTO:CMOTEC B) Equity-to-Asset : 0.28 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Scandinavian ChemoTech AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Scandinavian ChemoTech AB's Total Stockholders Equity for the quarter that ended in Mar. 2025 was kr3.70 Mil. Scandinavian ChemoTech AB's Total Assets for the quarter that ended in Mar. 2025 was kr13.07 Mil. Therefore, Scandinavian ChemoTech AB's Equity to Asset Ratio for the quarter that ended in Mar. 2025 was 0.28.

The historical rank and industry rank for Scandinavian ChemoTech AB's Equity-to-Asset or its related term are showing as below:

OSTO:CMOTEC B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.13   Med: 0.68   Max: 0.94
Current: 0.28

During the past 9 years, the highest Equity to Asset Ratio of Scandinavian ChemoTech AB was 0.94. The lowest was 0.13. And the median was 0.68.

OSTO:CMOTEC B's Equity-to-Asset is ranked worse than
77.66% of 1504 companies
in the Biotechnology industry
Industry Median: 0.675 vs OSTO:CMOTEC B: 0.28

Scandinavian ChemoTech AB Equity-to-Asset Historical Data

The historical data trend for Scandinavian ChemoTech AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scandinavian ChemoTech AB Equity-to-Asset Chart

Scandinavian ChemoTech AB Annual Data
Trend Jun15 Jun16 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.58 0.93 0.65 0.74 0.45

Scandinavian ChemoTech AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.49 0.22 0.61 0.45 0.28

Competitive Comparison of Scandinavian ChemoTech AB's Equity-to-Asset

For the Biotechnology subindustry, Scandinavian ChemoTech AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Scandinavian ChemoTech AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scandinavian ChemoTech AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Scandinavian ChemoTech AB's Equity-to-Asset falls into.


;
;

Scandinavian ChemoTech AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Scandinavian ChemoTech AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=5.98/13.38
=0.45

Scandinavian ChemoTech AB's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=3.697/13.069
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Scandinavian ChemoTech AB  (OSTO:CMOTEC B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Scandinavian ChemoTech AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Scandinavian ChemoTech AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Scandinavian ChemoTech AB Business Description

Traded in Other Exchanges
N/A
Address
Scheelevagen 1, Medicon Village, Lund, SWE, 223 63
Scandinavian ChemoTech AB is a Sweden based clinical development company. It is engaged in research on pain management and therapy for prostate cancer.

Scandinavian ChemoTech AB Headlines

No Headlines